These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 398530)

  • 1. Evaluation of mutagenicity of metronidazole and mizonidazole on the base of lambda prophage induction and Ames test.
    Gałkiewicz E; Pyziak M; Chomiczewski J; Górski T
    Radiobiol Radiother (Berl); 1979 Oct; 20(5):657-60. PubMed ID: 398530
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenic activity of radiosensitizers.
    Grzybowska E; Kalinowska E; Szala S
    Acta Microbiol Pol; 1985; 34(2):111-20. PubMed ID: 2412398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of procarbazine (MIH) on the induction of prophage lambda in Escherichia coli K12 and toxic effects on Salmonella typhimurium.
    Lackner F; Schüpbach ME
    Mutat Res; 1981 Nov; 90(3):247-54. PubMed ID: 6460182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of prophage induction and mutagenicity in Ames tester strains by alkylating agents.
    Wheeler L; Halula M; DeMeo M
    Proc West Pharmacol Soc; 1979; 22():261-4. PubMed ID: 390539
    [No Abstract]   [Full Text] [Related]  

  • 5. [Toxic and radiosensitizing effect of reduced nitroimidazoles on E. coli B/r cells].
    Riabchenko NI; Semin IuA; Petrova KM; Kutmin AI
    Radiobiologiia; 1983; 23(4):505-9. PubMed ID: 6351162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metronidazole and misonidazole on some metabolic parameters of normal tissues in mice.
    Bara A; Mustea I
    Radiobiol Radiother (Berl); 1980; 21(4):453-8. PubMed ID: 7455028
    [No Abstract]   [Full Text] [Related]  

  • 7. On the mutagenicity of nitroimidazoles.
    Voogd CE
    Mutat Res; 1981 May; 86(3):243-77. PubMed ID: 6457989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the anticholinesterase activity of metronidazole and misonidazole.
    Von Burg R; Conroy PJ
    Eur J Pharmacol; 1979 May; 55(4):417-20. PubMed ID: 467496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mutagenic action of nitroimidazoles. I. Metronidazole, nimorazole, dimetridazole and ronidazole.
    Voogd CE; Van der Stel JJ; Jacobs JJ
    Mutat Res; 1974 Dec; 26(6):483-90. PubMed ID: 4610373
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA damage induced by reductively activated nitroimidazoles--pH effects.
    Edwards DI; Knight RC; Zahoor A
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1207-9. PubMed ID: 3528090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.
    Lindmark DG; Müller M
    Antimicrob Agents Chemother; 1976 Sep; 10(3):476-82. PubMed ID: 791102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity evaluation of KB-944, a new calcium antagonist, in the Ames bacterial system.
    Tanaka H; Tanaka A; Tsunetoshi Y; Sotomura M; Nose T
    Arzneimittelforschung; 1982; 32(9):1087-8. PubMed ID: 6756416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of metronidazole (Flagyl) and misonidazole (Ro-07-0582): enhancement by lactate.
    Mahood JS; Willson RL
    Br J Cancer; 1981 Mar; 43(3):350-4. PubMed ID: 7225286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronidazole (flagyl) and misonidazole (Ro-07-0582): reduction by facultative anaerobes and cytotoxic action on hypoxic bacteria and mammalian cells in vivo.
    Basag SH; Dunlop JR; Searle AJ; Willson RL
    Br J Cancer Suppl; 1978 Jun; 3():132-5. PubMed ID: 354677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vivo investigation of the radiosensitization of metastases by nitroimidazoles.
    Davies BM; Watling DC
    Int J Radiat Oncol Biol Phys; 1978; 4(9-10):809-19. PubMed ID: 711550
    [No Abstract]   [Full Text] [Related]  

  • 16. The organospecific activity of metronidazole and azanidazole in the intrasanguineous host-mediated assay.
    Cantelli-Forti G; Hrelia P; Paolini M; Bronzetti G; Biagi GL
    Drugs Exp Clin Res; 1985; 11(11):755-9. PubMed ID: 3915465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenic activities of simple nitrofuran derivatives. I. Comparison of related compounds in the phage inductest, chloroplast-bleaching and bacterial-repair and mutagenicity tests.
    Soska J; Koukalová B; Ebringer L
    Mutat Res; 1981 Mar; 81(1):21-6. PubMed ID: 6454838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophage induction and mutagenicity of a series of anti-tumour platinum(II) and platinum(IV) co-ordination complexes.
    Mattern IE; Cocchiarella L; van Kralingen CG; Lohman PH
    Mutat Res; 1982 Aug; 95(2-3):79-93. PubMed ID: 6214710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory effects and ascorbate reactions with misonidazole and other recently developed drugs.
    Jacobson B; Biaglow JE; Fielden EM; Adams GE
    Cancer Clin Trials; 1980; 3(1):47-53. PubMed ID: 7389037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression by hypoxic cell radiosensitizers: a phenomenon of potential clinical importance.
    Rockwell S; Kapp DS
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1071-3. PubMed ID: 7050051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.